{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:32:53Z","timestamp":1792528373410,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>COVID-19 and its related anti-inflammatory treatment (steroids, immunomodulators) may induce the reactivation of latent bacterial, parasitic, and viral infections. According to our knowledge, no case of disseminated HHV-8-related Kaposi sarcoma (KS) after COVID-19 and its treatment has been described so far. Only one case of cutaneous KS concurrently with COVID-19 has been previously reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe a case of disseminated KS in a 61-year-old immunocompetent Albanian man after hospitalization for COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods for literature research<\/jats:title>\n                <jats:p>We used PubMed as biomedical database for the literature research. We selected keyword combinations including \u201cKaposi sarcoma,\u201d \u201cHHV-8,\u201d \u201cimmunocompetent,\u201d \u201cCOVID-19,\u201d \u201cSARS-CoV-2,\u201d and \u201csteroids.\u201d No time or language limitation was set. Titles and abstracts of selected articles were systematically screened. Articles were included in the examination if they were published under free access through the digital library of the University of Brescia (Italy), and provided full text. Articles were excluded if the topic was beyond the aim of our study. Finally, we selected 15 articles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We describe a case of KS in COVID-19 patient and postulate that Interleukin-6 (IL-6) activity and steroid-induced immunodeficiency may play a major role in KS emergence. No published case of disseminated KS following COVID-19 in otherwise healthy individuals was found through the systematic literature review, despite the high incidence of COVID-19 in areas with medium\u2013high prevalence of HHV-8 infection. This observation might be explained by the role of individual genetic susceptibility factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SARS-CoV-2 infection and its treatment may lead to reactivation of several latent infections, including HHV-8 and its related clinical syndrome, Kaposi sarcoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-021-00620-9","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T16:03:53Z","timestamp":1640016233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-3495","authenticated-orcid":false,"given":"Giulia","family":"Gardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Odolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Moioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea Angela","family":"Papalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Matteelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Caligaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"issue":"3","key":"620_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s15010-020-01522-4","volume":"49","author":"V Marchese","year":"2021","unstructured":"Marchese V, Crosato V, Gulletta M, Castelnuovo F, Cristini G, Matteelli A, Castelli F. Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia. Infection. 2021;49(3):539\u201342. https:\/\/doi.org\/10.1007\/s15010-020-01522-4 (Epub 2020 Sep 10).","journal-title":"Infection"},{"issue":"1","key":"620_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jvh.13410","volume":"28","author":"S Rodr\u00edguez-Tajes","year":"2021","unstructured":"Rodr\u00edguez-Tajes S, Miralpeix A, Costa J, L\u00f3pez-Su\u00f1\u00e9 E, Laguno M, Pocurull A, Lens S, Mari\u00f1o Z, Forns X. Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy. J Viral Hepat. 2021;28(1):89\u201394. https:\/\/doi.org\/10.1111\/jvh.13410 (Epub 2020 Oct 12).","journal-title":"J Viral Hepat"},{"key":"620_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/bjd.19484","volume":"183","author":"R Xu","year":"2020","unstructured":"Xu R, et al. Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br J Dermatol. 2020;183:1145\u20137.","journal-title":"Br J Dermatol"},{"key":"620_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/ijd.15001","volume":"59","author":"F Tartari","year":"2020","unstructured":"Tartari F, et al. Herpes zoster in COVID-19-positive patients. Int J Dermatol. 2020;59:1028\u20139.","journal-title":"Int J Dermatol"},{"key":"620_CR5","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/jmv.26549","volume":"93","author":"F Drago","year":"2021","unstructured":"Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus 6, 7 and Epstein Barr virus reactivation in pityriasis rosea during COVID-19. J Med Virol. 2021;93:1850\u20131.","journal-title":"J Med Virol"},{"issue":"5","key":"620_CR6","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1111\/jdv.17123","volume":"35","author":"E Leoni","year":"2021","unstructured":"Leoni E, Cerati M, Finzi G, Lombardo M, Sessa F. COVID-19 and HHV8 first spotted together: an affair under electron microscopy. J Eur Acad Dermatol Venereol. 2021;35(5):e311\u20132. https:\/\/doi.org\/10.1111\/jdv.17123 (Epub 2021 Feb 5).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"620_CR7","unstructured":"Krown ES, Chadha Singh J. Classic Kaposi sarcoma: clinical features, staging, diagnosis, and treatment. https:\/\/www.uptodate.com\/contents\/classic-kaposi-sarcoma-clinical-features-staging-diagnosis-andtreatment?search=sarcoma%20kaposi&source=search_result&selectedTitle=3~150&usage_type=default&display_rank=3. Accessed date 7 June 21."},{"key":"620_CR8","unstructured":"Casper C. Disease associations of human herpesvirus 8 infection. https:\/\/www.uptodate.com\/contents\/disease-associations-of-human-herpesvirus-8infection?search=hhv8&source=search_result&selectedTitle=1~78&usage_type=default&display_rank=1. Accessed date 7 June 21."},{"issue":"5","key":"620_CR9","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3346\/jkms.2009.24.5.970","volume":"24","author":"B Kim","year":"2009","unstructured":"Kim B, Jeon YK, Kim CW. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and Kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case. J Korean Med Sci. 2009;24(5):970\u20134. https:\/\/doi.org\/10.3346\/jkms.2009.24.5.970 (Epub 2009 Sep 24).","journal-title":"J Korean Med Sci"},{"issue":"1","key":"620_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/01.pas.0000172293.59785.b4","volume":"30","author":"CF Li","year":"2006","unstructured":"Li CF, Ye H, Liu H, Du MQ, Chuang SS. Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). Am J Surg Pathol. 2006;30(1):123\u20137. https:\/\/doi.org\/10.1097\/01.pas.0000172293.59785.b4.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"620_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0609.2007.00828.x","volume":"78","author":"A Re","year":"2007","unstructured":"Re A, Facchetti F, Borlenghi E, Cattaneo C, Capucci MA, Ungari M, Barozzi P, Vallerini D, Potenza L, Torelli G, Rossi G, Luppi M. Fatal hemophagocytic syndrome related to active human herpesvirus-8\/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies. Eur J Haematol. 2007;78(4):361\u20134. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00828.x (Epub 2007 Jan 22).","journal-title":"Eur J Haematol"},{"issue":"7","key":"620_CR12","doi-asserted-by":"publisher","DOI":"10.12890\/2016_000493","volume":"3","author":"H Zoubeidi","year":"2016","unstructured":"Zoubeidi H, Aydi Z, Daoud F, Rachdi I, Koubaa W, Jouini R, Baili L, Debbiche A, Ben Dhaou B, Boussema F. Kaposi\u2019s sarcoma presenting as lymphadenopathy in an immunocompetent patient. Eur J Case Rep Intern Med. 2016;3(7): 000493. https:\/\/doi.org\/10.12890\/2016_000493.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"10","key":"620_CR13","doi-asserted-by":"publisher","first-page":"13030\/qt1d6409w","DOI":"10.5070\/D32110028948","volume":"21","author":"AG Florek","year":"2015","unstructured":"Florek AG, Eilers D, Armstrong AW. A case of Kaposi sarcoma in an immunocompetent, heterosexual Irish man: a discussion of etiology and viral transmission. Dermatol Online J. 2015;21(10):13030\/qt1d6409wz.","journal-title":"Dermatol Online J"},{"issue":"3","key":"620_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/000348940811700303","volume":"117","author":"AG Sikora","year":"2008","unstructured":"Sikora AG, Shnayder Y, Yee H, DeLacure MD. Oropharyngeal Kaposi sarcoma in related persons negative for human immunodeficiency virus. Ann Otol Rhinol Laryngol. 2008;117(3):172\u20136. https:\/\/doi.org\/10.1177\/000348940811700303.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"620_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jdcr.2017.04.012","volume":"3","author":"T Hinojosa","year":"2017","unstructured":"Hinojosa T, Lewis DJ, Liu M, Garza G, Vangipuram R, Ramos E, Salas-Alanis JC, Nawas ZY, Tyring SK. Nonepidemic Kaposi sarcoma: a recently proposed category. JAAD Case Rep. 2017;3(5):441\u20133. https:\/\/doi.org\/10.1016\/j.jdcr.2017.04.012.","journal-title":"JAAD Case Rep"},{"issue":"1","key":"620_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3315\/jdcr.2012.1088","volume":"6","author":"I Altunay","year":"2012","unstructured":"Altunay I, Kucukunal A, Demirci GT, Ates B. Variable clinical presentations of classic Kaposi sarcoma in Turkish patients. J Dermatol Case Rep. 2012;6(1):8\u201313. https:\/\/doi.org\/10.3315\/jdcr.2012.1088.","journal-title":"J Dermatol Case Rep"},{"issue":"6","key":"620_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30(6):1\u20139. https:\/\/doi.org\/10.1002\/rmv.2141 (Epub 2020 Aug 26).","journal-title":"Rev Med Virol"},{"key":"620_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.02.324228","author":"J Chen","year":"2020","unstructured":"Chen J, Dai L, Barrett L, Post SR, Qin Z. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.10.02.324228.","journal-title":"bioRxiv"},{"issue":"5","key":"620_CR19","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/10970142(19930901)72:5<1779::aid-cncr2820720543>3.0.co;2-m","volume":"72","author":"A Trattner","year":"1993","unstructured":"Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer. 1993;72(5):1779\u201383. https:\/\/doi.org\/10.1002\/10970142(19930901)72:5%3c1779::aid-cncr2820720543%3e3.0.co;2-m.","journal-title":"Cancer"},{"issue":"3","key":"620_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1066896917736610","volume":"26","author":"AL Windon","year":"2018","unstructured":"Windon AL, Shroff SG. Iatrogenic Kaposi\u2019s sarcoma in an HIV-negative young male with Crohn\u2019s disease and IgA nephropathy: a case report and brief review of the literature. Int J Surg Pathol. 2018;26(3):276\u201382. https:\/\/doi.org\/10.1177\/1066896917736610 (Epub 2017 Nov 23).","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"620_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/ced.13151","volume":"42","author":"L Brambilla","year":"2017","unstructured":"Brambilla L, Esposito L, Nazzaro G, Tourlaki A. Onset of Kaposi sarcoma and Merkel cell carcinoma during low-dose steroid therapy for rheumatic polymyalgia. Clin Exp Dermatol. 2017;42(6):702\u20134. https:\/\/doi.org\/10.1111\/ced.13151 (Epub 2017 Jun 9).","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"620_CR22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0956462420980644","volume":"32","author":"KZ Htet","year":"2021","unstructured":"Htet KZ, Waul M, Edelstein H, Mui S, Cherny S, Leslie K. Primary nasal Kaposi sarcoma in well-controlled HIV-positive patient with normal CD4 count associated with long-term nasal steroid use. Int J STD AIDS. 2021;32(6):582\u20134. https:\/\/doi.org\/10.1177\/0956462420980644 (Epub 2021 Feb 3).","journal-title":"Int J STD AIDS"},{"issue":"3","key":"620_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10067-005-0148-3","volume":"26","author":"S Simeoni","year":"2007","unstructured":"Simeoni S, Puccetti A, Moruzzi S, Tinazzi E, Peterlana D, Lunardi C. Dermatomyositis complicated with Kaposi sarcoma: a case report. Clin Rheumatol. 2007;26(3):440\u20132. https:\/\/doi.org\/10.1007\/s10067-005-0148-3 (Epub 2006 Jan 26).","journal-title":"Clin Rheumatol"},{"issue":"4","key":"620_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2230.2005.01795.x","volume":"30","author":"MT Fierro","year":"2005","unstructured":"Fierro MT, Savoia P, Quaglino P, Novero D, Bernengo MG. Disseminated Kaposi\u2019s sarcoma associated with idiopathic CD4+ lymphocytopenia and low dose steroid therapy. Clin Exp Dermatol. 2005;30(4):395\u20137. https:\/\/doi.org\/10.1111\/j.1365-2230.2005.01795.x.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"620_CR25","first-page":"1","volume":"26","author":"R Graffeo","year":"2003","unstructured":"Graffeo R, Ranno S, Marchetti S, Capodicasa N, Schito AM, Fuga L, Amico R, Cattani P, Fadda G. HHV 8 seroprevalence and transmission within Albanian family groups. New Microbiol. 2003;26(1):1\u20136.","journal-title":"New Microbiol"},{"issue":"5","key":"620_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/b:ejep.0000027358.38997.66","volume":"19","author":"N Schinaia","year":"2004","unstructured":"Schinaia N, Kodra Y, Sarmati L, Andreoni M, Bino S, Qyra S, Rezza G. Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV. Eur J Epidemiol. 2004;19(5):467\u20139. https:\/\/doi.org\/10.1023\/b:ejep.0000027358.38997.66.","journal-title":"Eur J Epidemiol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-021-00620-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T16:06:25Z","timestamp":1640016385000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-021-00620-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s40001-021-00620-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this study we used the general authorization of the Italian Guarantor for the use of retrospective demographical and clinical data, which have been anonymized and treated according to Italian current laws.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave an informed consent for this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}